Log In
Print this Print this

NPC-1C ELISA (Serum ELISA assay)

  Manage Alerts
Collapse Summary General Information
Company Precision Biologics Inc.
DescriptionSerum biomarker ELISA using a chimeric mAb derived from immunogenic glycoprotein to detect NPC-1C antigen on colorectal and pancreatic tumors
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose colorectal and pancreatic cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today